TradingView
warrenhochfeld
20 lis 2017 19:43
Second Axsome AXSM buy opportunity
Long
NASDAQ:AXSM
120
Axsome Therapeutics, Inc.
NASDAQ
Opis
⋅
20 lis 2017 19:43
Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.
Trend Analysis
Beyond Technical Analysis
Więcej